Pancreatic cancer is a particularly devastating disease. At least 94 percent of patients will die within five years, and in 2013 it was ranked as one of the top 10 deadliest cancers.
Routine screenings for breast, colon and lung cancers have improved treatment and outcomes for patients with these diseases, largely because the cancer can be detected early. But because little is known about how pancreatic cancer behaves, patients often receive a diagnosis when it’s already too late.
University of Washington scientists and engineers are developing a low-cost device that could help pathologists diagnose pancreatic cancer earlier and faster. The prototype can perform the basic steps for processing a biopsy, relying on fluid transport instead of human hands to process the tissue. The team presented its initial results this month (February 2014) at the SPIE Photonics West conference and recently filed a patent for this first-generation device and future technology advancements.
“This new process is expected to help the pathologist make a more rapid diagnosis and be able to determine more accurately how invasive the cancer has become, leading to improved prognosis,” said Eric Seibel, a UW research professor of mechanical engineering and director of the department’s Human Photonics Laboratory.
The new instrumentation would essentially automate and streamline the manual, time-consuming process a pathology lab goes through to diagnose cancer. Currently, a pathologist takes a biopsy tissue sample, then sends it to the lab where it’s cut into thin slices, stained and put on slides, then analyzed optically in 2-D for abnormalities.
The UW’s technology would process and analyze whole tissue biopsies for 3-D imaging, which offers a more complete picture of the cellular makeup of a tumor, said Ronnie Das, a UW postdoctoral researcher in bioengineering who is the lead author on a related paper.
“As soon as you cut a piece of tissue, you lose information about it. If you can keep the original tissue biopsy intact, you can see the whole story of abnormal cell growth. You can also see connections, cell morphology and structure as it looks in the body,” Das said.
The research team is building a thick, credit card-sized, flexible device out of silicon that allows a piece of tissue to pass through tiny channels and undergo a series of steps that replicate what happens on a much larger scale in a pathology lab. The device harnesses the properties of microfluidics, which allows tissue to move and stop with ease through small channels without needing to apply a lot of external force. It also keeps clinicians from having to handle the tissue; instead, a tissue biopsy taken with a syringe needle could be deposited directly into the device to begin processing.
Researchers say this is the first time material larger than a single-celled organism has successfully moved in a microfluidic device. This could have implications across the sciences in automating analyses that usually are done by humans.
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Pancreatic Cancer Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027on June 26, 2020 at 10:53 am
The Global Pancreatic Cancer Market is estimated to value over USD 4.7 billion by 2027 end with a CAGR of over ...
- AIkido Pharma Inc. Provides Update to Machine Learning Pancreatic Cancer Researchon June 26, 2020 at 7:38 am
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced an update to its machine learning driven pancreatic cancer research.
- Former Sen. Harry Reid Says He's in 'Complete Remission' After Pancreatic Cancer Treatmenton June 25, 2020 at 8:37 am
Former Sen. Harry Reid tells PEOPLE that he's in "complete remission" from pancreatic cancer after undergoing an experimental therapy treatment created by Dr. Patrick Soon-Shiong ...
- For 16th Consecutive Year, Pancreatic Cancer Action Network Awarded Four-Star Rating From Charity Navigatoron June 24, 2020 at 5:26 am
For 16th Consecutive Year, Pancreatic Cancer Action Network Awarded Four-Star Rating From Charity NavigatorPR NewswireMANHATTAN BEACH, Calif., June 24, 2020Fewer Than One Percent of All Rated ...
- A synergic approach to enhance long-term culture and manipulation of MiaPaCa-2 pancreatic cancer spheroidson June 23, 2020 at 2:58 am
Tumour spheroids have the potential to be used as preclinical chemo-sensitivity assays. However, the production of three-dimensional (3D) tumour spheroids remains challenging as not all tumour cell ...
- Couple’s Engagement Encourages Single Mother Battling Pancreatic Canceron June 22, 2020 at 4:41 pm
When 29-year-old Maggie Erickson pulled up to St. Paul's Neighborhood Cafe on Friday she knew this was different.
- AACR: Attacking pancreatic cancer by thwarting its survival strategieson June 22, 2020 at 6:35 am
At this week’s virtual meeting of the American Association for Cancer Research (AACR), several research groups are presenting new therapeutic tactics aimed at interrupting survival pathways in ...
- Pancreatic Cancer Therapeutics Market 2020 Analysis report with Cross-Channel, Opportunities, Upturn Growth by 2026on June 19, 2020 at 3:51 am
The report provides rational insights along with historical and forecast data to aid in better understanding of ...
- 5 for Good: Local families advocate for support in fighting pancreatic canceron June 18, 2020 at 8:35 pm
To recognize it early, because that can really make a difference in the survival rate." Improved in recent years, the survival rate for pancreatic cancer patients is still very low. According to the ...
- Researchers find a new therapeutic target in pancreatic canceron June 18, 2020 at 8:02 am
The development of pancreatic cancer is driven by co-existing mutations in an oncogene involved in controlling cell growth, called KRAS, and in a tumor suppressor gene, called p53. But how these ...
via Bing News